Inventors list

Assignees list

Classification tree browser

Top 100 Inventors

Top 100 Assignees


Engelhard, US

Eric K. Engelhard, Davis, CA US

Patent application numberDescriptionPublished
20090148833DEVICES FOR GENERATING DETECTABLE POLYMERS - This document provides systems, devices, and methods involved in generating detectable polymers. For example, diagnostic systems, diagnostic devices, primer systems, and collections of primer systems are provided.06-11-2009
20100105025DEVICES FOR GENERATING DETECTABLE POLYMERS - This document provides systems, devices, and methods involved in generating detectable polymers. For example, diagnostic systems, diagnostic devices, primer systems, and collections of primer systems are provided.04-29-2010
20100216713NOVEL COMPOSITIONS AND METHODS IN CANCER ASSOCIATED WITH ALTERED EXPRESSION OF PRLR - The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially breast cancers. In addition, the present invention describes the use of novel compositions for use in screening methods. The invention provides compositions and methods associated with altered expression of PRLR in cancer.08-26-2010
20100317003NOVEL COMPOSITIONS AND METHODS IN CANCER WITH ALTERED EXPRESSION OF KCNJ9 - The present invention relates to novel sequences for use in diagnosis and treatment of carcinomas, especially breast cancers. In addition, the present invention describes the use of novel compositions for use in screening methods.12-16-2010

Patent applications by Eric K. Engelhard, Davis, CA US

Rolf Engelhard, Prescott, AZ US

Patent application numberDescriptionPublished
20080302735APPARATUS AND METHOD FOR REMOVING ARSENIC AND INORGANIC COMPOSITIONS FROM WATER - Simultaneous application of ozone and ultraviolet light (UV185 and UV254) in water to be purified will create hydroxyl radicals, which combination will cause conversion of AS (III) that may be present to As (V), oxidation of inorganic matter such as manganese, sulfur, phosphorus and organic matter and provide virucidal and germicidal effects to purify the water.12-11-2008
20080302737APPARATUS AND METHOD FOR PURIFYING WATER IN A STORAGE TANK - A pressurized water tank having a head space includes a pump for recirculating the water through a nozzle disposed in the head space. The outflowing stream of water will entrain air and cause mixing of air entrained water with the remaining water in the tank. To enhance air entrainment and convey the air entrained water to a location well below the water level, the stream of water is injected into a vertical venturi tube. The entrained air will have an oxidizing effect upon organic matter and also cause circulation of the water within the tank. To enhance oxidation of organic and inorganic matter, a UV lamp may be located in the head space to convert oxygen molecules in the air into ozone molecules. Such ozone molecules would be entrained in the stream of water flowing out of the nozzle and into the tube and have a strong oxidizing effect upon organic and inorganic matter. UV radiation from the UV lamp will also have a virucidal and germicidal effect upon microorganisms on the surface of the water and in water to some depth below the water surface. To further enhance oxidation of organic matter and the virucidal and germicidal effect of ultraviolet light, the UV lamp is mounted within the water toward the bottom of the tank. The outlet of the tube extends into the tank to a location proximate the UV lamp. The air entrained water flowing out of the tube would be subjected to UV irradiation to convert oxygen molecules entrained in the water into ozone molecules. As the ozone and oxygen molecules migrate upwardly, the will perform an oxidizing function. Moreover the water flowing from the tube in and about a UV lamp would be irradiated and produce a disinfecting effect.12-11-2008
20090001029APPARATUS AND METHOD FOR TREATING WATER WITH OZONE - Water within a water tank is irradiated with ultraviolet light from a UV lamp for virucidal and germicidal purposes while simultaneously transforming oxygen molecules to ozone molecules in an oxygen containing gas flowing within an annular space defined by a sleeve surrounding the UV lamp. The ozone enriched gas flows into an enlarged chamber into which the UV lamp extends and the flow rate is reduced to enhance the time of exposure of the ozone enriched gas to UV radiation and thereby enhance the production of ozone. To increase the rate of transformation of oxygen molecules to ozone molecules, the gas is under a predetermined pressure prior to entering the annular space and subsequent to discharge from the chamber.01-01-2009
20100143205HIGH INTENSITY AIR PURIFIER - This document describes a high intensity air purifier (HAIP), a super oxidation purifier, and a controller for controlling operation of any of various purification systems. In some implementations, a HAIP includes an air purifier system coupled within a housing having an air inlet and an air outlet. The air purifier system includes a pre-filter coupled to the air inlet, an axial fan for receiving and forwarding air from the air inlet. The air purifier system further includes a UV reaction chamber having a UV-light source for providing UV light to the forwarded air from the air inlet and a reflective lining to reflect the provided UV light, to provide UV purified air from the UV reaction chamber. The air purifier system further includes a chemical catalyst cartridge for receiving the UV purified air from the UV reaction chamber, for further purifying the UV purified air, and a post filter coupled to the air outlet.06-10-2010

Patent applications by Rolf Engelhard, Prescott, AZ US

Victor H. Engelhard, Crozet, VA US

Patent application numberDescriptionPublished
20080254037METHOD OF TREATING ISCHEMIA REPERFUSION INJURY BY INHIBING NKT CELL ACTIVITY - The present invention relates to a method for treating recurrent tumor metastases following liver resection that includes administration of an effective amount of an agonist of A10-16-2008

Victor H. Engelhard, Charlottesville, VA US

Patent application numberDescriptionPublished
20080206268HA-1 epitopes and uses thereof - Peptide sequences constituting T-cell epitopes of minor Histocompatibility antigen, HA-1. HA-1 is associated with Graft versus Host Disease. The peptides and their derivatives find many uses, for instance, in bone marrow transplantation, organ transplantation and in treatment of leukemia and non-hematopoietic tumors. The peptide and/or its derivatives can be incorporated in vaccines, in pharmaceutical formulations and they can be used in diagnostic test kits. HA-1 is expressed by non-hematopoietic tumor cells. While absent in normal epithelial cells, tumor cells and tumor cell lines, particularly from epithelial origin, express HA-1 and are recognized by HA-1 cytotoxic T-cells. The invention provides means and methods for HA-1 specific immunotherapy for HA-1-positive patients with non-hematopoietic tumor cells.08-28-2008